PortfoliosLab logoPortfoliosLab logo
HMY vs. RIGL
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

HMY vs. RIGL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Harmony Gold Mining Company Limited (HMY) and Rigel Pharmaceuticals, Inc. (RIGL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HMY achieves a -18.77% return, which is significantly higher than RIGL's -23.30% return. Over the past 10 years, HMY has outperformed RIGL with an annualized return of 17.69%, while RIGL has yielded a comparatively lower 3.28% annualized return.


HMY

1D
4.27%
1M
-9.63%
YTD
-18.77%
6M
-20.76%
1Y
8.74%
3Y*
55.21%
5Y*
29.67%
10Y*
17.69%

RIGL

1D
2.40%
1M
2.24%
YTD
-23.30%
6M
-19.45%
1Y
54.23%
3Y*
27.10%
5Y*
-3.96%
10Y*
3.28%
*Multi-year figures are annualized to reflect compound growth (CAGR)

HMY vs. RIGL - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
HMY
Harmony Gold Mining Company Limited
-18.77%145.47%35.39%82.51%-16.42%-10.25%28.93%102.79%-4.28%-12.94%
RIGL
Rigel Pharmaceuticals, Inc.
-23.30%154.64%16.00%-3.33%-43.40%-24.29%63.55%-6.96%-40.72%63.03%

Correlation

The correlation between HMY and RIGL is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.15

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.09

Correlation (10Y)
Calculated over the trailing 10-year period

0.07

Correlation (All Time)
Calculated using the full available price history since Nov 29, 2000

0.07

Fundamentals

Market Cap

HMY:

$9.49B

RIGL:

$646.69M

EPS

HMY:

ZAR 41.64

RIGL:

$19.21

PE Ratio

HMY:

0.36

RIGL:

1.71

PEG Ratio

HMY:

0.00

RIGL:

0.00

PS Ratio

HMY:

0.06

RIGL:

2.08

PB Ratio

HMY:

0.18

RIGL:

1.62

Total Revenue (TTM)

HMY:

ZAR 150.28B

RIGL:

$299.77M

Gross Profit (TTM)

HMY:

ZAR 57.55B

RIGL:

$279.95M

EBITDA (TTM)

HMY:

ZAR 55.56B

RIGL:

$125.80M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HMY vs. RIGL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HMY
HMY Risk / Return Rank: 4444
Overall Rank
HMY Sharpe Ratio Rank: 4444
Sharpe Ratio Rank
HMY Sortino Ratio Rank: 4545
Sortino Ratio Rank
HMY Omega Ratio Rank: 4444
Omega Ratio Rank
HMY Calmar Ratio Rank: 4545
Calmar Ratio Rank
HMY Martin Ratio Rank: 4444
Martin Ratio Rank

RIGL
RIGL Risk / Return Rank: 6767
Overall Rank
RIGL Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
RIGL Sortino Ratio Rank: 7070
Sortino Ratio Rank
RIGL Omega Ratio Rank: 6969
Omega Ratio Rank
RIGL Calmar Ratio Rank: 6565
Calmar Ratio Rank
RIGL Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HMY vs. RIGL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Harmony Gold Mining Company Limited (HMY) and Rigel Pharmaceuticals, Inc. (RIGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HMYRIGLDifference
Sharpe ratioReturn per unit of total volatility

-0.64

Sortino ratioReturn per unit of downside risk

-0.99

Omega ratioGain probability vs. loss probability

1.08

1.20

-0.12

Calmar ratioReturn relative to maximum drawdown

0.18

1.09

-0.91

Martin ratioReturn relative to average drawdown

0.40

1.91

-1.51

HMY vs. RIGL - Sharpe Ratio Comparison

The current HMY Sharpe Ratio is 0.14, which is lower than the RIGL Sharpe Ratio of 0.78. The chart below compares the historical Sharpe Ratios of HMY and RIGL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

HMY vs. RIGL - Drawdown Comparison

The maximum HMY drawdown since its inception was -97.04%, roughly equal to the maximum RIGL drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for HMY and RIGL.


Loading charts...

Drawdown Indicators


HMYRIGLDifference

Max Drawdown

Largest peak-to-trough decline

-97.04%

-99.37%

+2.33%

Max Drawdown (1Y)

Largest decline over 1 year

-48.85%

-50.08%

+1.23%

Max Drawdown (3Y)

Largest decline over 3 years

-48.85%

-57.75%

+8.90%

Max Drawdown (5Y)

Largest decline over 5 years

-62.48%

-85.24%

+22.76%

Max Drawdown (10Y)

Largest decline over 10 years

-71.05%

-86.40%

+15.35%

Current Drawdown

Current decline from peak

-37.92%

-96.93%

+59.01%

Average Drawdown

Average peak-to-trough decline

-52.74%

-90.91%

+38.17%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.98%

28.64%

-6.66%

Volatility

HMY vs. RIGL - Volatility Comparison

Harmony Gold Mining Company Limited (HMY) has a higher volatility of 21.33% compared to Rigel Pharmaceuticals, Inc. (RIGL) at 12.05%. This indicates that HMY's price experiences larger fluctuations and is considered to be riskier than RIGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HMYRIGLDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.33%

12.05%

+9.28%

Volatility (6M)

Calculated over the trailing 6-month period

48.63%

36.64%

+11.99%

Volatility (1Y)

Calculated over the trailing 1-year period

64.67%

69.89%

-5.22%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

58.53%

85.46%

-26.93%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

61.20%

82.81%

-21.61%

Dividends

HMY vs. RIGL - Dividend Comparison

HMY's dividend yield for the trailing twelve months is around 2.67%, while RIGL has not paid dividends to shareholders.


PositionTTM2025202420232022202120202019201820172016
HMY
Harmony Gold Mining Company Limited
2.53%1.07%1.59%0.66%1.14%2.23%0.00%0.00%0.00%3.13%1.37%
RIGL
Rigel Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

HMY vs. RIGL - Financials Comparison

This section allows you to compare key financial metrics between Harmony Gold Mining Company Limited and Rigel Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00B20.00B30.00B40.00B50.00B202120222023202420252026
46.57B
58.82M
(HMY) Total Revenue
(RIGL) Total Revenue
Please note, different currencies. HMY values in ZAR, RIGL values in USD

HMY vs. RIGL - Profitability Comparison

The chart below illustrates the profitability comparison between Harmony Gold Mining Company Limited and Rigel Pharmaceuticals, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%202120222023202420252026
44.1%
92.2%
Portfolio components
HMY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Harmony Gold Mining Company Limited reported a gross profit of 20.53B and revenue of 46.57B. Therefore, the gross margin over that period was 44.1%.

RIGL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.

HMY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Harmony Gold Mining Company Limited reported an operating income of 19.36B and revenue of 46.57B, resulting in an operating margin of 41.6%.

RIGL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.

HMY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Harmony Gold Mining Company Limited reported a net income of 9.29B and revenue of 46.57B, resulting in a net margin of 19.9%.

RIGL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.


Frequently Asked Questions


HMY and RIGL have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HMY has higher volatility (21.33%) compared to RIGL (12.05%). In terms of maximum drawdown, HMY dropped -97.04% vs RIGL's -99.37%.

RIGL currently has the higher Sharpe Ratio (0.78 vs 0.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HMY and RIGL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer